Journal of Antimicrobial Chemotherapy (1999) 43, 579-582
© 1999 The British Society for Antimicrobial Chemotherapy
Brief report |
The antifungal activity of mupirocin
a SmithKline Beecham Pharmaceuticals, 1250 S. Collegeville Road, Collegeville, PA 19426, USA b Burnthouse, Burnthouse Lane, Cowfold, Sussex RH13 8DH c Schering Health Care, The Brow, Burgess Hill, West Sussex RH15 9NE, UK
The antibacterial agent mupirocin (pseudomonic acid A) is used as a topical agent in the treatment of superficial infections by Gram-positive bacteria, particularly Staphylococcus aureus. However, we demonstrate here that the compound also inhibits the growth of a number of pathogenic fungi in vitro, including a range of dermatophytes and Pityrosporum spp. It inhibited the incorporation of amino acids and precursors of RNA, but not that of acetate, by Trichophyton mentagrophytes. It also inhibited the isoleucyl-tRNA synthetase from Candida albicans, indicating a mechanism of action similar to that in bacteria. When administered topically, mupirocin was efficacious in a T. mentagrophytes ringworm model in guinea pigs. These results suggest that mupirocin could have clinical utility for superficial infections caused by dermatophytes.
* Corresponding author. Tel: +1-610-917-7000; Fax: +1-610-917-7901; E-mail: richard_o_nicholas{at}sbphrd.com
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. S. Nield and D. Kamat Prevention, Diagnosis, and Management of Diaper Dermatitis Clinical Pediatrics, July 1, 2007; 46(6): 480 - 486. [PDF] |
||||
